DALLABONA, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 2.085
EU - Europa 2.006
AS - Asia 1.004
AF - Africa 14
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 1
SA - Sud America 1
Totale 5.118
Nazione #
US - Stati Uniti d'America 2.065
IT - Italia 632
CN - Cina 592
SE - Svezia 442
IE - Irlanda 422
SG - Singapore 317
FI - Finlandia 202
DE - Germania 94
FR - Francia 57
UA - Ucraina 56
TR - Turchia 55
GB - Regno Unito 50
BE - Belgio 28
CA - Canada 19
IN - India 15
CI - Costa d'Avorio 10
HK - Hong Kong 8
IR - Iran 7
EU - Europa 6
PK - Pakistan 5
RU - Federazione Russa 5
CZ - Repubblica Ceca 3
ES - Italia 3
NL - Olanda 3
AT - Austria 2
KE - Kenya 2
LT - Lituania 2
PT - Portogallo 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
EG - Egitto 1
JP - Giappone 1
MX - Messico 1
PL - Polonia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 5.118
Città #
Dublin 411
Chandler 376
Singapore 257
Parma 174
Ann Arbor 172
Ashburn 146
Dearborn 142
Boardman 137
Beijing 131
Jacksonville 83
Shanghai 81
Nanjing 79
Princeton 69
Izmir 53
New York 52
Wilmington 43
Jinan 29
Los Angeles 29
Helsinki 28
Nanchang 28
Brussels 27
San Mateo 26
Shenyang 26
Woodbridge 25
Kunming 22
Marseille 22
Des Moines 21
Bologna 20
Hebei 18
Milan 18
Changsha 16
Colchester 15
Guangzhou 15
Hangzhou 15
Hefei 15
Santa Clara 15
Falls Church 14
Tianjin 14
Toronto 14
Redmond 13
Seattle 13
Fontanellato 11
Zhengzhou 11
Abidjan 10
Piacenza 10
Rome 10
Bremen 9
Houston 9
Pistoia 9
Bari 8
Dallas 8
Norwalk 8
Pune 8
Vicenza 8
Gravina di Catania 7
Vezzano sul Crostolo 7
Dosolo 6
Haikou 6
Washington 6
Grafing 5
Langhirano 5
Mardan 5
Munich 5
Newcastle Upon Tyne 5
Reggio Nell'emilia 5
Trezzano Sul Naviglio 5
Arnstadt 4
Avola 4
Brescia 4
Cagliari 4
Carpi 4
Ferrara 4
Jiaxing 4
Messina 4
Ottawa 4
Ravenna 4
Redwood City 4
Scafati 4
Zanjan 4
Chengdu 3
Chongqing 3
Este 3
Frankfurt am Main 3
Fremont 3
Fuzhou 3
Modena 3
Ningbo 3
Peterborough 3
Phoenix 3
Reggio Emilia 3
San Giovanni Valdarno 3
Taiyuan 3
Tappahannock 3
Xian 3
Ahmedabad 2
Argelato 2
Auburn Hills 2
Bellosguardo 2
Borås 2
Cambridge 2
Totale 3.199
Nome #
Yeast as a model system to shed light on the role of the human disease protein Mpv17 115
DNA polymerase [gamma] and disease: what we have learned from yeast 114
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 107
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 102
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 102
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 102
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 97
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 96
Yeast as a model system for diseases associated with defective coenzyme a metabolism 94
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 92
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 90
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 89
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 88
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 86
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 84
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 83
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 82
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 82
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 82
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 81
SYM1, l'ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 80
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 80
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 78
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 78
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 78
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 77
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 76
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 76
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 75
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 72
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 72
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 71
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 71
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 71
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 71
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 69
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 69
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 69
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 67
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 66
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 66
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 65
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 65
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 65
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 64
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 64
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 63
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 63
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 63
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 62
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 61
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 60
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 60
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 60
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 60
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 59
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 56
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 56
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 54
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 51
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 50
Role of ROS in mtDNA instability in ANT1-associated adPEO 50
Mitochondrial diseases and the role of the yeast models. 50
The power of yeast in modeling human mutations leading to mitochondrial disease 49
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 49
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 48
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 47
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 46
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 46
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 44
Novel (ovario) leukodystrophy related to AARS2 mutations 43
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 42
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 35
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 33
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 30
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 27
Yeast-based screening to discover therapies for Complex III assembly defects. 25
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 20
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 20
Epigenetic analyses in forensic medicine: future and challenges 19
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 15
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 13
Totale 5.352
Categoria #
all - tutte 20.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.316


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020436 0 0 0 0 48 110 78 22 75 55 23 25
2020/2021463 8 22 46 5 48 31 23 23 106 61 53 37
2021/2022407 22 21 1 27 14 27 36 37 14 33 28 147
2022/20231.478 141 151 102 96 136 157 28 83 505 7 51 21
2023/2024764 57 66 37 29 58 146 39 64 17 74 66 111
2024/2025542 44 91 123 143 141 0 0 0 0 0 0 0
Totale 5.352